Literature DB >> 19133278

Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effects.

Huibing Tan1, Stephanie F Bishop, Nicole M Lauzon, Ninglei Sun, Steven R Laviolette.   

Abstract

The mammalian ventral tegmental area (VTA) and associated mesolimbic dopamine (DA) system are critical neural substrates for processing nicotine's motivational effects. Considerable evidence suggests that the role of DA transmission may be altered as a function of nicotine exposure. Using a combination of in vivo neuronal recording and behavioral conditioning, we report that chronic nicotine exposure induces a functional switch in the role of mesolimbic DA transmission. Thus, in nicotine-naive subjects, blockade of DA transmission potentiates the rewarding effects of sub-reward-threshold doses of nicotine and reverses the motivational valence of nicotine from aversive to rewarding. However, in animals treated chronically with nicotine, DA blockade switches previously sub-reward-threshold or rewarding doses of nicotine into aversion signals. Neuronal VTA recordings similarly revealed a functional switch in this DAergic neuronal circuit resulting in strongly increased sensitivity of the VTA DAergic system to nicotine administration and a tonic reduction in the baseline activity of VTA DAergic neurons. These results demonstrate a functional switch in the role of DAergic transmission during the acute versus chronic phases of nicotine exposure and suggest that mesolimbic DA transmission plays qualitatively distinct roles in the processing of nicotine's motivational effects as a function of drug exposure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19133278     DOI: 10.1016/j.neuropharm.2008.12.008

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  18 in total

1.  Concurrent access to nicotine and sucrose in rats.

Authors:  Leigh V Panlilio; Lee Hogarth; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2014-11-01       Impact factor: 4.530

2.  Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal.

Authors:  Taryn E Grieder; Olivier George; Huibing Tan; Susan R George; Bernard Le Foll; Steven R Laviolette; Derek van der Kooy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-20       Impact factor: 11.205

3.  Changes in circulating leptin levels during acute stress and associations with craving in abstinent smokers: a preliminary investigation.

Authors:  Sheena Potretzke; Motohiro Nakajima; Tiffany Cragin; Mustafa al'Absi
Journal:  Psychoneuroendocrinology       Date:  2014-05-23       Impact factor: 4.905

Review 4.  Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.

Authors:  George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2017-01-03       Impact factor: 4.530

5.  Circulating orexin changes during withdrawal are associated with nicotine craving and risk for smoking relapse.

Authors:  Mustafa al'Absi; Andrine Lemieux; James S Hodges; Sharon Allen
Journal:  Addict Biol       Date:  2018-08-16       Impact factor: 4.280

6.  Dopamine receptor blockade modulates the rewarding and aversive properties of nicotine via dissociable neuronal activity patterns in the nucleus accumbens.

Authors:  Ninglei Sun; Steven R Laviolette
Journal:  Neuropsychopharmacology       Date:  2014-06-04       Impact factor: 7.853

7.  Deletion of α5 nicotine receptor subunits abolishes nicotinic aversive motivational effects in a manner that phenocopies dopamine receptor antagonism.

Authors:  Taryn E Grieder; Olivier George; Mandy Yee; Michael A Bergamini; Michal Chwalek; Geith Maal-Bared; Hector Vargas-Perez; Derek van der Kooy
Journal:  Eur J Neurosci       Date:  2017-06-21       Impact factor: 3.386

8.  Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens.

Authors:  Lifen Zhang; Yu Dong; William M Doyon; John A Dani
Journal:  Biol Psychiatry       Date:  2011-08-27       Impact factor: 13.382

9.  NMDA receptor blockade in the prelimbic cortex activates the mesolimbic system and dopamine-dependent opiate reward signaling.

Authors:  Huibing Tan; Laura G Rosen; Garye A Ng; Walter J Rushlow; Steven R Laviolette
Journal:  Psychopharmacology (Berl)       Date:  2014-05-29       Impact factor: 4.530

10.  Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System.

Authors:  Christopher Norris; Michael Loureiro; Cecilia Kramar; Jordan Zunder; Justine Renard; Walter Rushlow; Steven R Laviolette
Journal:  Neuropsychopharmacology       Date:  2016-06-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.